Is aromatase expression in the endometrium the cause of endometriosis and related infertility?

References

• Metzger D A, Szpak C A, Haney A F. Histologic features associated with hormonal responsiveness of ectopic endometrium. Fertil Steril 1993; 59: 83–88
   PubMedGoogle Scholar
• Leyendecker G, Herbertz M, Kunz G, Mall G. Endometriosis results from dislocation of basal endometrium. Hum Reprod 2003; 18: 1130–1131
   Google Scholar
• Eskenazi B, Warner M L. Epidemiology of endometriosis. Obstet Gynecol Clinics North Am 1997; 24: 235–258
   PubMed Web of Science ®Google Scholar
• Duleba A J. The diagnosis of endometriosis. Obstet Gyn Clin North Am 1997; 24: 331–345
   Google Scholar
• Sutton C JG, Pooley A S, Ewen S P, Haines P. Follow up report on a randomized controlled trial of laser laparoscopy in the treatment of pelvic pain associated with minimal to moderate endometriosis. Fertil Steril 1997; 78: 1070
   Google Scholar
• Miller J D, Shaw R W, Casper R F, Rock J A, Thomas E J, Dmowski W P, Surrey E, Malinak L R, Moghissi K. Historical prospective cohort study of the recurrence of pain after discontinuation of treatment with danazol or a gonadotrophin-releasing hormone agonist. Fertil Steril 1998; 70: 293–296
   PubMed Web of Science ®Google Scholar
• Jones K D, Haines P, Sutton C J. Long term follow-up of controlled trial of laser laparoscopy for pelvic pain. JSLS 2001; 5: 111–1115
   PubMedGoogle Scholar
• Jones K D, Sutton C J. Recurrence of chocolate cysts after laparoscopic ablation. J Am Assoc Gynec Laparosc 2002; 9: 315–320
   PubMedGoogle Scholar
• Olive D L. Medical treatment: alternative to danazol. Endometriosis: contemporary concepts in clinical management, R S Schenken. J. B. Lippincott, Philadelphia 1989; 189–211
   Google Scholar
• Signorello L B, Harlow B L, Cramer D W, Spiegelman D, Hill J A. Epidemiologic determinants of endometriosis: a hospital based case control study. Ann Epidemiol 1997; 7: 267–274
   PubMed Web of Science ®Google Scholar
• Cramer D W, Missmer S A. Epidemiology of endometriosis. Ann N Y Acad Sci 2002; 955: 11–22
   PubMed Web of Science ®Google Scholar
• Attaran M, Gidwani A P. Adolescent endometriosis. Obstetric Gynecol Clin North Am 2003; 30: 379–390
   PubMed Web of Science ®Google Scholar
• Hadfield R, Mardon H, Barlow D H, Kennedy S. Delay in diagnosis of endometriosis: a survey of women from the USA and the UK. Human Reprod 1996; 11: 878–880
   PubMed Web of Science ®Google Scholar
• Kitawaki J, Kado N, Ishihara H, Koshiba H, Kitaoka Y, Honjo H. Endometriosis: the pathophysiology as estrogen dependent diseases. J Steroid Biochem Mol Biol 2002; 83: 149–155
   PubMed Web of Science ®Google Scholar
• Ulukus M, Cakmak H, Arici A. The role of endometrium in endometriosis. J Soc Gynecol Investig 2006; 13: 467–476
   PubMedGoogle Scholar
• Bulun S E, Gurates B, Fang Z, Tamura M, Sebastian S, Zhou J, Amin S, Yang S. Mechanisms of excessive estrogen formation in endometriosis. J Reprod Immunol 2002; 55: 21–33
   PubMed Web of Science ®Google Scholar
• Attar E. Aromatase and other steroidogenic genes in endometriosis. Translational aspects. Hum Reprod Update 2006; 12: 49–56
   PubMed Web of Science ®Google Scholar
• Exacoustos C, Zupi E, Amadio A, Amoroso C, Szabolcs B, Romanini M E, Arduini D. Recurrence of endometriomas after laparoscopic removal: sonographic and clinical follow-up and indication for second surgery. J Minim Invasive Gynecol 2006; 13: 281–288
   PubMedGoogle Scholar
• Nieto A, Jacuri C, Serra M, Keller J, Cortes-Prieto J. Long term follow-up of endometriosis after two different therapies (gestrinone and buserelin). Clin Exp Obstet Gynecol 1996; 23: 198–204
   Google Scholar
• Bulun S E, Zeitoun K, Takayama K, Noble L, Michael D, Simpson E, Johns A, Putman M, Sasano H. Estrogen production in endometriosis and use of aromatase inhibitors to treat endometriosis. Endocrine Rel Cancer 1999; 6: 293–301
   PubMed Web of Science ®Google Scholar
• Velasco I, Rueda J, Acien P. Aromatase expression in endometriotic tissues and cell cultures of patients with endometriosis. Mol Hum Reprod 2006; 12: 377–381
   PubMed Web of Science ®Google Scholar
• Maia H, Jr, Casoy J, Correia T, Freitas A, Pimentel K, Coutinho E M. Effect of the menstrual cycle and oral contraceptives on aromatase and Cox-2 expression in adenomyosis. Gynecol Endocrinol 2006; 22: 1–5
   Web of Science ®Google Scholar
• Maia H, Jr, Pimentel K, Casoy J, Correia T, Freitas L A, Zausner B, Athayde C, Coutinho E. Aromatase expression in the eutopic endometrium of myomatous uteri: the influence of the menstrual cycle and oral contraceptive use. Gynecol Endocrinol 2007; 23: 320–324
   PubMed Web of Science ®Google Scholar
• Ishira H. Gonadotrophin-releasing hormone agonist and danazol normalize aromatase cytochrome p450 expression in eutopic endometrium from women with endometriosis, adenomyosis or leiomyomas. Fertil Steril 2003; 79(Suppl 1)735–742
   PubMedGoogle Scholar
• Kitawaki J, Noguchi T, Amatsu T, Maeda K, Tsukamoto K, Yamamoto T, Fushiki S, Osawa Y, Honjo H. Expression of aromatase cytochrome p450 protein and messenger ribonucleic acid in human endometriotic and adenomyotic tissues but not in normal endometrium. Biol Reprod 1997; 57: 514–519
   PubMed Web of Science ®Google Scholar
• Bukulmez O, Hardy D B, Carr B R, Word R A, Mendelson C R. Inflammatory status influences aromatase and steroid receptor expression in endometriosis. Endocrinology 2008; 149: 1190–1204
   PubMed Web of Science ®Google Scholar
• Noble L S. Prostaglandin E2 stimulates aromatase activity in endometriosis derived stromal cells. J Clin Endocrinol Metab 1997; 82: 600–606
   PubMed Web of Science ®Google Scholar
• Sidell N, Han S W, Parthasarathy S. Regulation and modulation of abnormal immune responses in endometriosis. Ann N Y Acad Sci 2002; 955: 159–173
   PubMed Web of Science ®Google Scholar
• Olive D L, Montoya I, Riehl R M, Schenken R S. Macrophage conditioned media enhance endometrial stroma proliferation in vitro. Am J Obstet Gynecol 1991; 164: 953–958
   PubMedGoogle Scholar
• Carlstein H. Immune responses and bone loss: the estrogen connection. Immunol Rev 2005; 208: 194–206, (Review)
   Google Scholar
• Capellino S, Montagna P, Villaggio B, Sulli A, Soldano S, Ferrero S, Remorgida V, Cutolo M. Role of estrogens in inflammatory response: expression of estrogen receptors in peritoneal fluid macrophages from endometriosis. Ann N Y Acad Sci 2006; 1069: 263–267
   PubMedGoogle Scholar
• Lebovic D I, Muller M D, Taylor R N. Immunobiology of endometriosis. Fertil Steril 2001; 75: 1
   PubMed Web of Science ®Google Scholar
• Bancz E, Kaminsky P, Marianovski L. Role of cytokines in pathogenesis of endometriosis. Med Sci Monit 2000; 6: 1042–1046
   Google Scholar
• D'Hooghe T M. Immunomodulators and aromatase inhibitors: are they the next generation of treatment for endometriosis. Curr Opin Obstet Gynecol 2003; 15: 243–249
   Google Scholar
• Fatemi H M, Al-Turki H A, Papanikolaou E G, Kosmas L, De Sutter P, Devroey P. Successful treatment of an aggressive recurrent post-menopausal endometriosis with an aromatase inhibitor. Reprod BioMed Online 2005; 11: 455–457
   PubMed Web of Science ®Google Scholar
• Acien P, Velasco I, Gutierrez M, Martinez-Beltran M. Aromatase expression in endometriotic tissues and its relationship to clinical and analytical findings. Fertil Steril 2007; 88: 32–38
   PubMed Web of Science ®Google Scholar
• Amsterdam L L, Gentry W, Jobanputra S, Wolf M, Rubin S D, Bulun S E. Anastrazole and oral contraceptives: a novel treatment for endometriosis. Fertil Steril 2005; 84: 300–304
   PubMed Web of Science ®Google Scholar
• Vottero A, Rochira V, Capelletti M, Viani I, Zirilli L, Neri T M, Neri T M, Carani C, Bernasconi S, Ghizzoni L. Aromatase is differentially expressed in peripheral blood leukocytes from children, and adult female and male subjects. Eur J Endocrinol 2006; 154: 425–431
   PubMedGoogle Scholar
• Fechner S, Husen B, Thole H, Schmidt M, Gashaw I, Kimmig R, Winterhager E, Grummer R. Expression and regulation of estrogen-converting enzymes in ectopic human endometrial tissue. Fertil Steril 2007; 88: 1029–1038
   PubMed Web of Science ®Google Scholar
• Fraser I S, Kovacs G T. The efficacy of non-contraceptive uses for hormonal contraceptives. MJA 2003; 178: 621–623
   PubMed Web of Science ®Google Scholar
• Maia H, Jr, Coelho G, Valente Filho J, Athayde C, Barbosa I C, Coutinho E M. Prevention of endometriotic cyst recurrence with continuous oral contraceptives. J Contraception Reprod Health 2004; v9: 152
   Google Scholar
• Bergqvist I A. Hormonal regulation of endometriosis and rationales and effects of gonadotrophin–releasing hormone treatment: a review. Hum Reprod 1995; 10: 446–452
   Google Scholar
• Scheppe K W. Current place for progestins in the treatment of endometriosis. Gynecol Endocrinol Suppl 2002; 6: 22–28
   Google Scholar
• Buttram V C, Belue J B, Reiter R. Interim report of a study of danazol for the treatment of endometriosis. Fertil Steril 1982; 37: 478–483
   PubMed Web of Science ®Google Scholar
• Telimaa S, Puolakka J, Ronnberg L, Kaupilla A. Placebo-controlled comparison of danazol and high dose medroxyprogesterone acetate in the treatment of endometriosis. Gynecol Endocrinol 1987; 1: 13
   PubMedGoogle Scholar
• Surrey E S, Halme J. Direct effects of medroxyprogesterone acetate, danazol and leuprolide acetate on endometrial stroma cell proliferation in vitro. Fertil Steril 1992; 58: 273–278
   Google Scholar
• Braun D P, Gebel H, Dmowski W P. Effect of danazol in vitro and in vivo on monocyte-mediated enhancement of endometrial cell proliferation in women with endometriosis. Fertil Steril 1994; 62: 89–95
   Google Scholar
• Selak V, Farquhr C, Prentice A, Singla A. Danazol for pelvic pain associated with endometriosis. Cochrane Database Syst Rev 2007, 4: CD000068
   Google Scholar
• Igarashi M, Lizuka M, Abe Y, Ibuki Y. Novel vaginal danazol ring therapy for pelvic endometriosis, in particular deeply infiltrating endometriosis. Hum Reprod 1998; 13: 1952–1956
   PubMed Web of Science ®Google Scholar
• Brosens J, Verhoeven H, Campo R, Gianaroli L, Gordts S, Hazekamp J, Hägglund L, Mardesic T, Varila E, Zech J, Brosens I. High endometrial aromatase P450 mRNA expression is associated with poor IVF outcome. Hum Reprod 2004; 19: 352–356
   PubMed Web of Science ®Google Scholar
• Chisei Tei, Mivazaki T, Kuji N, Tanaka M, Sueoka K, Yoshimura Y. Effect of danazol on the pregnancy rate in patients with unsuccessful in vitro fertilization-embryo transfer. J Reprod Med 1998; 43: 541–546
   Google Scholar
• Maia H, Jr, Casoy J, Coreia T, Freitas L A, Pimentel K, Athayde C. The effect of oral contraceptives on aromatase expression in the eutopic endometrium of patients with endometriosis. Gynecol Endocrinol 2008; 24: 123–128
   PubMed Web of Science ®Google Scholar